Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Open accessThe DOI matches its Crossref record; 334 of the 334 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–334 of 334
COX‐2 and Neurodegeneration in Parkinson's Disease
TEISMANN, P., VILA, M., CHOI, D. ‐., TIEU, K., WU, D. C., JACKSON‐LEWIS, V., & PRZEDBORSKI, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07482.x · Cited by 178
The Role of Microglia and Astrocytes in Cns Immune Surveillance and Immunopathology
Aloisi, F. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_10 · Cited by 177
Lipoxygenases and their involvement in programmed cell death
Maccarrone, M., Melino, G., & Finazzi-Agro, A. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400908 · Cited by 176
Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175 · cited 3×
“…by secretion of microglialderived neuroprotective factors which act to limit tissue damage and promote repair (WyssCoray and Mucke, 2002; Marchetti and Abbracchio, 2005), chronic neuroinflammation is more likely to increase the susceptibility of vulnerable neurons to toxic injury…”
BackgroundSearching for a relationship between manganese and welding and Parkinson’s disease
Jankovic, J. (2005) · Neurology · doi:10.1212/01.wnl.0000166916.40902.63 · Cited by 175
Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling
Henn, I. H., Bouman, L., Schlehe, J. S., Schlierf, A., Schramm, J. E., Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5537-06.2007 · Cited by 173
Neuroinflammation, COX-2, and ALS—a dual role?
Consilvio, C., Vincent, A. M., & Feldman, E. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.009 · Cited by 172
Minghetti, L., Ajmone-Cat, M. A., De Berardinis, M. A., & De Simone, R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.015 · Cited by 168
Kloss, C. U. A., Bohatschek, M., Kreutzberg, G. W., & Raivich, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7575 · Cited by 168
Delgado, M., & Ganea, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0799fje · Cited by 166
Sugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164
Carvey, P. M. (2003) · Frontiers in Bioscience · doi:10.2741/1158 · Cited by 161
Ling, Z., Zhu, Y., Tong, C. W., Snyder, J. A., Lipton, J. W., & Carvey, P. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.010 · Cited by 160
Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R., & Hong, J.-S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160
Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2
Shang, F., Lu, M., Dudek, E. J., Reddan, J. R., & Taylor, A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01304-7 · Cited by 159
Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer, P. L., & McGeer, E. G. (1998) · PubMed · Cited by 158
Vawter, M. P., Dillon-Carter, O., Tourtellotte, W. W., Carvey, P., & Freed, W. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0200 · Cited by 158
Bessler, H., Djaldetti, R., Salman, H., Bergman, M., & Djaldetti, M. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80079-1 · Cited by 157
Oxidative Stress and Parkinson's Diseasea
OWEN, A. D., SCHAPIRA, A. H. V., JENNER, P., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 155
Wilms, H., Claasen, J., Röhl, C., Sievers, J., Deuschl, G., & Lucius, R. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.002 · Cited by 154
4‐Hydroxy‐2(E)‐Nonenal Inhibits CNS Mitochondrial Respiration at Multiple Sites
Picklo, M. J., Amarnath, V., McIntyre, J. O., Graham, D. G., & Montine, T. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721617.x · Cited by 153
Rhodes, K. E., Raivich, G., & Fawcett, J. W. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.055 · Cited by 152
Thorsen, P., Jensen, I. P., Jeune, B., Ebbesen, N. T., Arpi, M., Bremmelgaard, A., & Møller, B. R. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70442-9 · Cited by 149
α-Synuclein Expression Modulates Microglial Activation Phenotype
Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 142
Nagatsu, T., & Sawada, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9061-9 · Cited by 141
Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease
Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.836 · Cited by 141
The Epidemiology of Parkinson's Disease: A Case-Control Study of Young-Onset and Old-Onset Patients
Stern, M. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530210029018 · Cited by 139
Diagnostic staging of Parkinson?s disease: conceptual aspects
Przuntek, H., M�ller, T., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0102-y · Cited by 138
Genetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 137
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects
Zucca, F. A., Giaveri, G., Gallorini, M., Albertini, A., Toscani, M., Pezzoli, G., Lucius, R., Wilms, H., Sulzer, D., Ito, S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00201.x · Cited by 134
Duke, D. C., Moran, L. B., Pearce, R. K. B., & Graeber, M. B. (2007) · Neurogenetics · doi:10.1007/s10048-006-0077-6 · Cited by 133
Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.
Tanner, C. M. (2003) · PubMed · Cited by 131
Mitochondrial glutathione: Hepatocellular survival–death switch
Garcia‐Ruiz, C., & Fernandez‐Checa, J. C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04570.x · Cited by 130
Rockwell, P., Yuan, H., Magnusson, R., & Figueiredo-Pereira, M. E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1646 · Cited by 130 · cited 1×
“…and activity of the proinflammatory cyclooxygenase COX-2 and these in turn enhance oxidative stress and further prostaglandin production which can feed back in a positive toxic loop and affect UPS function (Rockwell et al., 2000; Figueiredo-Pereira et al., 2002; Li et al., 2003, 2004a,b).”
BackgroundMultiple sclerosis: a battle between destruction and repair
McQualter, J. L., & Bernard, C. C. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04232.x · Cited by 130
Zhao, Y., Li, S., Childs, E. E., Kuharsky, D. K., & Yin, X.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102465200 · Cited by 128
Bohatschek, M., Werner, A., & Raivich, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7764 · Cited by 128
Arai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122 · cited 1×
“IL-1β levels have been reported to increase rapidly after nigral administration of LPS in mice and neuroprotection can be achieved with nigral administration of an anti-IL-1β neutralizing antibody (Arai et al., 2004; Arai et al., 2006).”
BackgroundAge-dependent synuclein pathology following traumatic brain injury in mice
Uryu, K., Giasson, B. I., Longhi, L. G., Martínez, D., Murray, I. V. J., Conte, V., Nakamura, M., Saatman, K. E., Talbot, K., Horiguchi, T., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00245-0 · Cited by 121
Delgado, M., & Ganea, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-1029fje · Cited by 119
A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease
Zecca, L., Zucca, F. A., Albertini, A., Rizzio, E., & Fariello, R. G. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s8 · Cited by 118
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
Kurkowska-Jastrzębska, I., Litwin, T., Joniec, I., Ciesielska, A., Przybyłkowski, A., Członkowski, A., & Członkowska, A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.006 · Cited by 117
Herrera, A. J., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0121-3 · Cited by 116
A rat model of Parkinson's disease induced by Japanese encephalitis virus
Ogata, A., Tashiro, K., Nukuzuma, S., Nagashima, K., & Hall, W. W. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709015803 · Cited by 115
Jin, J., Shie, F.-S., Liu, J., Wang, Y., Davis, J., Schantz, A. M., Montine, K. S., Montine, T. J., & Zhang, J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-2 · Cited by 109
Postencephalitic parkinsonism – a review
Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 108
Sairam, K., Saravanan, K. S., Banerjee, R., & Mohanakumar, K. P. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04174-4 · Cited by 106
Cookson, M. (2003) · Neuron · doi:10.1016/s0896-6273(02)01166-2 · Cited by 105
Schwab, J. M., Beschorner, R., Meyermann, R., Gözalan, F., & Schluesener, H. J. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.5.0892 · Cited by 102
Aggregates in neurodegenerative disease: crowds and power?
Tran, P. B., & Miller, R. J. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01409-5 · Cited by 101
Laurie, C. D., Reynolds, A., Coskun, O., Bowman, E., Gendelman, H. E., & Mosley, R. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.009 · Cited by 100
TNF-α antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain
Heldmann, U., Thored, P., Claasen, J.-H., Arvidsson, A., Kokaia, Z., & Lindvall, O. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.024 · Cited by 100
Yasuhara, R., Miyamoto, Y., Akaike, T., Akuta, T., Nakamura, M., Takami, M., Morimura, N., Yasu, K., & Kamijo, R. (2005) · Biochemical Journal · doi:10.1042/bj20041996 · Cited by 100
Paraoxonase 1 Met–Leu 54 polymorphism is associated with Parkinson’s disease
Akhmedova, S. N., Yakimovsky, A. K., & Schwartz, E. I. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00439-7 · Cited by 97
Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease
Nishimura, M., Mizuta, I., Mizuta, E., Yamasaki, S., Ohta, M., Kaji, R., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02111-5 · Cited by 95
Microglial cells in neurodegenerative disorders.
Wojtera, M., Sikorska, B., Sobów, T., & Liberski, P. P. (2005) · PubMed · Cited by 94
Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP
Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 94
Aloisi, F., Serafini, B., & Adorini, L. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00231-9 · Cited by 93
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 93
Jung, Y.-J., & Surh, Y. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00548-2 · Cited by 89
Distinct roles of diverse nuclear factor-κB complexes in neuropathological mechanisms
Pizzi, M., & Spano, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.027 · Cited by 88
Carvey, P. M., Chen, E.-Y., Lipton, J. W., Tong, C. W., Chang, Q. A., & Ling, Z. D. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0222-z · Cited by 87
Lindå, H., Hammarberg, H., Piehl, F., Khademi, M., & Olsson, T. P. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00135-6 · Cited by 85
Parkinson's disease and inflammatory changes
Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 85
Mogi, M., Togari, A., Tanaka, K., Ogawa, N., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00388-2 · Cited by 85
Hemmer, K., Fransen, L., Vanderstichele, H., Vanmechelen, E., & Heuschling, P. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00119-4 · Cited by 84
Up-regulation of Connexin43 in the glial scar following photothrombotic ischemic injury
Haupt, C., Witte, O. W., & Frahm, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.005 · Cited by 83
Sterka, D., Rati, D. M., & Marriott, I. (2006) · Glia · doi:10.1002/glia.20286 · Cited by 83
Håkansson, A., Westberg, L., Nilsson, S., Buervenich, S., Carmine, A., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 83
Chapter 30 Nitric oxide: cellular regulation and neuronal injury
Dawson, T. M., Zhang, J., Dawson, V. L., & Snyder, S. H. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61150-4 · Cited by 82
Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)
Yazdani, U., German, D. C., Liang, C., Manzino, L., Sonsalla, P. K., & Zeevalk, G. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.002 · Cited by 82
The novel second messenger ceramide: identification, mechanism of action, and cellular activity.
Hannun, Y. A., Obeid, L. M., & Wolff, R. A. (1993) · PubMed · Cited by 80
CARD15 variants in patients with sporadic Parkinson’s disease
Bialecka, M., Kurzawski, M., Klodowska-Duda, G., Opala, G., Juzwiak, S., Kurzawski, G., Tan, E.-K., & Drozdzik, M. (2007) · Neuroscience Research · doi:10.1016/j.neures.2006.11.012 · Cited by 79 · cited 2×
“, 2001) have recently been shown to be over-represented in patients with sporadic PD (Bialecka et al., 2007).”
BackgroundPrior history of head trauma in Parkinson's disease
Factor, S. A., & Weiner, W. J. (1991) · Movement Disorders · doi:10.1002/mds.870060306 · Cited by 77
Li, Z., Melandri, F. D., Berdo, I., Jansen, M., Hunter, L., Wright, S., Valbrun, D., & Figueiredo‐Pereira, M. E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.098 · Cited by 77
Hasegawa, Y., Inagaki, T., Sawada, M., & Suzumura, A. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.101003159.x · Cited by 76
Head trauma as a risk factor for Parkinson's disease
Stern, M. B. (1991) · Movement Disorders · doi:10.1002/mds.870060202 · Cited by 74
Aloe, L., & Fiore, M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00850-1 · Cited by 73
Barcia, C., de Pablos, V., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Bernal, I., Fernández‐Villalba, E., Martín, J., Bañón, R., Fernández-Barreiro, A., & Herrero, M. T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.05.006 · Cited by 73
Inhibition of microglial inflammation by the MLK inhibitor CEP‐1347
Lund, S., Porzgen, P., Mortensen, A. L., Hasseldam, H., Bozyczko‐Coyne, D., Morath, S., Hartung, T., Bianchi, M., Ghezzi, P., Bsibsi, M., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03014.x · Cited by 72
Familial Parkinson's disease. Alpha-synuclein and parkin.
Mizuno, Y., Hattori, N., Kitada, T., Matsumine, H., Mori, H., Shimura, H., Kubo, S., Kobayashi, H., Asakawa, S., Minoshima, S., et al. (2001) · PubMed · Cited by 72
Parkinson's disease: from causes to mechanisms
Corti, O., Hampe, C., Darios, F. D., Ibáñez, P., Ruberg, M., & Brice, A. (2004) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.10.009 · Cited by 71
Lin, S., Wei, X., Xu, Y., Yan, C., Dodel, R., Zhang, Y., Liu, J., Klaunig, J. E., Farlow, M., & Du, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02442-6 · Cited by 70 · cited 2×
“Thus, general anti-oxidants (Ling et al., 1999; Gao et al., 2002a, 2003; Isacson, 2002; Lin et al., 2003) are being intensely investigated for their ability to offer DA neuroprotec-tion in experimental models of PD. Evidence that the cycle of neuroinflammation triggered by exogenous neurotoxins…”
BackgroundNF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53
Liang, Z., Li, Y., Zhao, X.-L., Han, R., Wang, X., Wang, Y., Chase, T. N., Bennett, M. C., & Qin, Z. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.130 · Cited by 70
TNF‐induced death of adult human oligodendrocytes is mediated by c‐jun NH2‐terminal kinase‐3
Jurewicz, A., Matysiak, M., Tybor, K., & Selmaj, K. (2003) · Brain · doi:10.1093/brain/awg146 · Cited by 70 · cited 2×
“Both Bid-dependent and Bid-independent mitochondrial activation occurs early in response to TNF and while the Bid-mediated mechanism is rapid and potent, the Bid-independent mechanism progresses gradually and involves multiple players, including ROS, JNK, and mitochondria permeability transition (MPT) (Jurewicz et al.…”
BackgroundFigueiredo‐Pereira, M. E., Li, Z., Jansen, M., & Rockwell, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109145200 · Cited by 70
Mandel, S. A., Grünblatt, E., & Youdim, M. B. H. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_7 · Cited by 69
Genetics of Parkinson's disease and biochemical studies of implicated gene products: Commentary
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00377-0 · Cited by 69
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_14 · Cited by 67
Ling, Z. D., Robie, H. C., Tong, C. W., & Carvey, P. M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38124-8 · Cited by 66
Depino, A. M., Ferrari, C. C., Godoy, M. C. P., Tarelli, R., & Pitossi, F. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.009 · Cited by 66
Beyer, M., Gimsa, U., Ey�poglu, I. Y., Hailer, N. P., & Nitsch, R. (2000) · Glia · doi:10.1002/1098-1136(200009)31:3<262::aid-glia70>3.0.co;2-2 · Cited by 65
Weller, C., Oxlade, N., Dobbs, S. M., Dobbs, R. J., Charlett, A., & Bjarnason, I. T. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2005.01.011 · Cited by 64
Gene Expression Profiles of Reactive Astrocytes in Dopamine‐depleted Striatum
Nakagawa, T., & Schwartz, J. P. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00064.x · Cited by 64
Mogi, M., Togari, A., Tanaka, K.-I., Ogawa, N., Ichinose, H., & Nagatsu, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01275-1 · Cited by 63
Norris, E. H., & Giasson, B. I. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.672 · Cited by 62
An Inflammatory Pathomechanism for Parkinsons Disease?
Wersinger, C., & Sidhu, A. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055760 · Cited by 60
Weller, C., Charlett, A., Oxlade, N. L., Dobbs, S. M., Dobbs, R. J., Peterson, D. W., & Bjarnason, I. T. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00329.x · Cited by 60
Inflammation and infection in Parkinson's disease.
Arai, H., Furuya, T., Mizuno, Y., & Mochizuki, H. (2006) · PubMed · doi:10.14670/hh-21.673 · Cited by 59
Choi, H. J., Lee, S. Y., Cho, Y., No, H., Kim, S. W., & Hwang, O. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.10.011 · Cited by 59
Veluthakal, R., Palanivel, R., Zhao, Y., McDonald, P. J., Gruber, S. A., & Kowluru, A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0431-4 · Cited by 58
Neuroimmunophilin ligands in the treatment of Parkinson's disease
Gold, B. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00125-4 · Cited by 57
Novel modulators of amyloid‐β precursor protein processing
Tang, B. L., & Liou, Y. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04215.x · Cited by 57
Ju, W., & Neufeld, A. H. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10400 · Cited by 56
Marshall, K., Reist, M., Jenner, P. G., & Halliwell, B. B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00094-5 · Cited by 54
Mild parkinsonism in persons exposed to 1‐methyl‐4‐phenyl‐1,2,3,6‐ tetrahydropyridine (MPTP)
Tetrud, J. W., Langston, J. W., Garbe, P. L., et al. (1989) · Neurology · doi:10.1212/wnl.39.11.1483 · Cited by 53
Ito, S., Sawada, M., Haneda, M., Ishida, Y., & Isobe, K. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.07.009 · Cited by 52
Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation
Li, Z., Jansen, M., Pierre, S.-R., & Figueiredo‐Pereira, M. E. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00384-9 · Cited by 51
Japanese encephalitis and parkinsonism
Shoji, H., Watanabe, M., Itoh, S., Kuwahara, H., & Hattori, F. (1993) · Journal of Neurology · doi:10.1007/bf00838449 · Cited by 51
Investigation of genes coding for inflammatory components in Parkinson's disease
Håkansson, A., Westberg, L., Nilsson, S., Buervenich, S., Carmine, A., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · Movement Disorders · doi:10.1002/mds.20378 · Cited by 50
Parkinsonism: differential age‐trend in Helicobacter pylori antibody
Dobbs, Charlett, Dobbs, Weller, & Peterson (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00815.x · Cited by 47
Chen, X., Ding, W., Ni, H., Gao, W., Shi, Y., Gambotto, A. A., Fan, J., Beg, A. A., & Yin, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01166-06 · Cited by 47
Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease
Leng, A., Mura, A., Feldon, J., & Ferger, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.077 · Cited by 46
Inflammation and Parkinsons Disease
Wersinger, C., & Sidhu, A. (2002) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010023344580 · Cited by 45
Saavedra, A., Baltazar, G., & Duarte, E. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.019 · Cited by 45
A Role for Tumor Necrosis Factor α in Death of Dopaminergic Neurons Following Neural Transplantation
Clarke, D. J., & Branton, R. L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7911 · Cited by 45
Heterogeneous Phenotype in a Family With Compound Heterozygous Parkin Gene Mutations
Deng, H., Le, W.-D., Hunter, C., Ondo, W. G., Guo, Y., Xie, W., & Jankovic, J. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.273 · Cited by 45
Dopamine‐dependent neurotoxicity of lipopolysaccharide in substantia nigra
De Pablos, R. M., Herrera, A. J., Villarán, R. F., Cano, J., & Machado, A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2153fje · Cited by 45
Li, Z., Jansen, M., Ogburn, K. D., Salvatierra, L., Hunter, L., Mathew, S., & Figueiredo‐Pereira, M. E. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20346 · Cited by 43
Alcohol-induced liver disease: when fat and oxidative stress meet
Fernández-Checa, J. C. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32144-1 · Cited by 43
PINK1, a gene product of PARK6, accumulates in -synucleinopathy brains
Murakami, T., Moriwaki, Y., Kawarabayashi, T., Nagai, M., Ohta, Y., Deguchi, K., Kurata, T., Morimoto, N., Takehisa, Y., Matsubara, E., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100123 · Cited by 42
Nishimura, M., Kuno, S., Kaji, R., Yasuno, K., & Kawakami, H. (2005) · Movement Disorders · doi:10.1002/mds.20477 · Cited by 41
Nayernouri, T. (1985) · Surgical Neurology · doi:10.1016/0090-3019(85)90035-7 · Cited by 40
Klegeris, A., & McGeer, P. L. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7517 · Cited by 38
Opioid receptors in midbrain dopaminergic regions of the rat I. MU receptor autoradiography
German, D. C., Speciale, S. G., Manaye, K. F., & Sadeq, M. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244917 · Cited by 37
Models of repair mechanisms for future treatment modalities of Parkinson’s disease
Isacson, O. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00773-0 · Cited by 32
Hamaue, N., Ogata, A., Terado, M., Ohno, K., Kikuchi, S., Sasaki, H., Tashiro, K., Hirafuji, M., & Minami, M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9197-5 · Cited by 29
Alpha-synuclein studies are negative in postencephalic parkinsonism of von Economo
Josephs, K. A., Parisi, J. E., & Dickson, D. W. (2002) · Neurology · doi:10.1212/wnl.59.4.645 · Cited by 24
Inflamación y enfermedad de Parkinson
Barcia, C., & Herrero, M. T. (2004) · Revista de Neurología · doi:10.33588/rn.3806.2004033 · Cited by 22
Parkin polymorphisms and environmental exposure: Decrease in age at onset of Parkinson's disease
Ghione, I., Fonzo, A. D., Saladino, F., Bo, R. D., Bresolin, N., Comi, G. P., & Rango, M. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.01.004 · Cited by 17
Brain proteome of mice lacking the receptors for tumor necrosis factor α
Pejović, V., Šoškić, V., Pan, W., & Kastin, A. J. (2004) · PROTEOMICS · doi:10.1002/pmic.200300687 · Cited by 13
Migraine with aura. A risk factor for unprovoked seizures in children?
Wöber, C., & Wöber‐Bingöl, Ç. (2006) · Annals of Neurology · doi:10.1002/ana.20842 · Cited by 10
Grigoryan, G., Gray, J. A., Rashid, T., Chadwick, A. J., & Hodges, H. (2000) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2000-00158 · Cited by 10
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
From endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
“There is also evidence for a link between neuro-inflammatory processes and oxidative stress, which may be mediated by the overproduction of free radicals by activated glial cells during inflammatory states, and/or via the activation of the cyclooxygenase (COX) and lipoxygenase (LOX) pathways or pro-inflammatory cytoki…”
BackgroundSaijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957
“These observations are consistent with the possibility that environmental factors, such as infection, may interact with common but less penetrant susceptibility genes to influence the onset of most commonly observed sporadic PD cases (Tansey et al., 2007).”
Metadata
- Authors
- Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 208
- Issue
- 1
- Pages
- 1-25
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2138192231
- Cited by
- 583
- References
- 334
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.